Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy
- Substances:AnastrozoleCamizestrant+6
France- Participants:18–64 years · 65+ years
- Substances:Anastrozole
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to France93 clinical trials in Pringy, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, lung cancer, and pancreatic adenocarcinoma. Studies evaluate novel combination therapies and treatment approaches for advanced stages of these diseases.
Emphasis on personalized medicine approaches and treatment optimization for patients with various cancer types.
Research initiatives examining treatments for multiple myeloma and lymphoma, including investigations of novel drug combinations and therapy duration optimization.
Focus on improving outcomes for patients with blood-related cancers through innovative therapeutic strategies.
Studies investigating treatments for atrial fibrillation and acute coronary syndrome, with emphasis on anticoagulation management and monitoring systems.
Integration of modern technology with traditional treatment approaches for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.